Mir, S.A.; Dar, A.; Alshehri, S.A.; Wahab, S.; Hamid, L.; Almoyad, M.A.A.; Ali, T.; Bader, G.N.
Exploring the mTOR Signalling Pathway and Its Inhibitory Scope in Cancer. Pharmaceuticals 2023, 16, 1004.
https://doi.org/10.3390/ph16071004
AMA Style
Mir SA, Dar A, Alshehri SA, Wahab S, Hamid L, Almoyad MAA, Ali T, Bader GN.
Exploring the mTOR Signalling Pathway and Its Inhibitory Scope in Cancer. Pharmaceuticals. 2023; 16(7):1004.
https://doi.org/10.3390/ph16071004
Chicago/Turabian Style
Mir, Suhail Ahmad, Ashraf Dar, Saad Ali Alshehri, Shadma Wahab, Laraibah Hamid, Mohammad Ali Abdullah Almoyad, Tabasum Ali, and Ghulam Nabi Bader.
2023. "Exploring the mTOR Signalling Pathway and Its Inhibitory Scope in Cancer" Pharmaceuticals 16, no. 7: 1004.
https://doi.org/10.3390/ph16071004
APA Style
Mir, S. A., Dar, A., Alshehri, S. A., Wahab, S., Hamid, L., Almoyad, M. A. A., Ali, T., & Bader, G. N.
(2023). Exploring the mTOR Signalling Pathway and Its Inhibitory Scope in Cancer. Pharmaceuticals, 16(7), 1004.
https://doi.org/10.3390/ph16071004